These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2338605)

  • 1. Sustained-release of urease from a poloxamer gel matrix.
    Fults KA; Johnston TP
    J Parenter Sci Technol; 1990; 44(2):58-65. PubMed ID: 2338605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced stability of two model proteins in an agitated solution environment using poloxamer 407.
    Wang PL; Johnston TP
    J Parenter Sci Technol; 1993; 47(4):183-9. PubMed ID: 8410567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inulin disposition following intramuscular administration of an inulin/poloxamer gel matrix.
    Johnston TP; Miller SC
    J Parenter Sci Technol; 1989; 43(6):279-86. PubMed ID: 2600734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained release of lidocaine from Poloxamer 407 gels.
    Ricci EJ; Lunardi LO; Nanclares DM; Marchetti JM
    Int J Pharm; 2005 Jan; 288(2):235-44. PubMed ID: 15620863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo release of albumin using a biodegradable MPEG-PCL diblock copolymer as an in situ gel-forming carrier.
    Hyun H; Kim YH; Song IB; Lee JW; Kim MS; Khang G; Park K; Lee HB
    Biomacromolecules; 2007 Apr; 8(4):1093-100. PubMed ID: 17326678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activity of urease formulated in poloxamer 407 after intraperitoneal injection in the rat.
    Pec EA; Wout ZG; Johnston TP
    J Pharm Sci; 1992 Jul; 81(7):626-30. PubMed ID: 1403693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained delivery of interleukin-2 from a poloxamer 407 gel matrix following intraperitoneal injection in mice.
    Johnston TP; Punjabi MA; Froelich CJ
    Pharm Res; 1992 Mar; 9(3):425-34. PubMed ID: 1614979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poloxamer 407 as a solubilising agent for tolfenamic acid and as a base for a gel formulation.
    Cafaggi S; Russo E; Caviglioli G; Parodi B; Stefani R; Sillo G; Leardi R; Bignardi G
    Eur J Pharm Sci; 2008 Sep; 35(1-2):19-29. PubMed ID: 18598763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained release of 5-FU from Poloxamer gels interpenetrated by crosslinking chitosan network.
    Chung TW; Lin SY; Liu DZ; Tyan YC; Yang JS
    Int J Pharm; 2009 Dec; 382(1-2):39-44. PubMed ID: 19666095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterisation of modified poloxamer 407 thermoresponsive depot systems containing cubosomes.
    Kojarunchitt T; Hook S; Rizwan S; Rades T; Baldursdottir S
    Int J Pharm; 2011 Apr; 408(1-2):20-6. PubMed ID: 21272624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimensional changes, gel layer evolution and drug release studies in hydrophilic matrices loaded with drugs of different solubility.
    Efentakis M; Pagoni I; Vlachou M; Avgoustakis K
    Int J Pharm; 2007 Jul; 339(1-2):66-75. PubMed ID: 17408891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diffusion behaviors of drugs in thermosensitive in situ gels].
    Wei G; Lu WY; Zheng JM
    Yao Xue Xue Bao; 2004 Mar; 39(3):232-5. PubMed ID: 15171663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation and in vitro corneal retention behavior of novel cationic microemulsion/in situ gel system].
    Ma SW; Gan Y; Gan L; Zhu CL; Zhu JB
    Yao Xue Xue Bao; 2008 Jul; 43(7):749-55. PubMed ID: 18819481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pluronic F-127 gels as a vehicle for topical formulations of indomethacin and rheological behaviour of these formulations.
    Shawesh A; Kallioinen S; Hellén L; Antikainen O; Yliruusi J
    Pharmazie; 2002 Mar; 57(3):186-90. PubMed ID: 11933848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation into the characteristics and drug release properties of multiple W/O/W emulsion systems containing low concentration of lipophilic polymeric emulsifier.
    Vasiljevic D; Parojcic J; Primorac M; Vuleta G
    Int J Pharm; 2006 Feb; 309(1-2):171-7. PubMed ID: 16406403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled release of morphine from a poloxamer 407 gel.
    Jansen MM; Verzijl JM; Burger DM; Hekster YA
    Int J Pharm; 2013 Aug; 452(1-2):266-9. PubMed ID: 23707252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and preliminary in vivo dog studies of a novel drug delivery system for the treatment of periodontitis.
    Kelly HM; Deasy PB; Ziaka E; Claffey N
    Int J Pharm; 2004 Apr; 274(1-2):167-83. PubMed ID: 15072793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyacetal and poly(ortho ester)-poly(ethylene glycol) graft copolymer thermogels: preparation, hydrolysis and FITC-BSA release studies.
    Schacht E; Toncheva V; Vandertaelen K; Heller J
    J Control Release; 2006 Nov; 116(2):219-25. PubMed ID: 16962198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
    Duvvuri S; Janoria KG; Mitra AK
    J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of temperature-sensitive poly(N-isopropylacrylamide)-b-poly(D,L-lactide) microspheres for protein delivery.
    Liu SQ; Yang YY; Liu XM; Tong YW
    Biomacromolecules; 2003; 4(6):1784-93. PubMed ID: 14606909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.